Author

Christine Marosi

Professor Onkologie Medizinische Universit

Biography

Christine Marosi is a well-known researcher working in Department of Internal Medicine and has extended valuable service for many years and has been a recipient of many awards and grants.
Title
Cited by
Year
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...The Lancet Oncology 20 (10), e566-e581, 2019201
390
2019
Homeopathic treatment as an add‐on therapy may improve quality of life and prolong survival in patients with non‐small cell lung cancer: A prospective, randomized, placebo …
M Frass, P Lechleitner, C Gründling, C Pirker, E Grasmuk‐Siegl, ...The oncologist 25 (12), e1930-e1955, 2020202
36
2020
Determining medical decision-making capacity in brain tumor patients: why and how?
A Pace, JAF Koekkoek, MJ Van Den Bent, HJ Bulbeck, J Fleming, R Grant, ...Neuro-oncology practice 7 (6), 599-612, 2020202
28
2020
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
MJ Mair, A Wöhrer, J Furtner, A Simonovska, B Kiesel, S Oberndorfer, ...Journal of Neuro-oncology 148, 187-198, 2020202
27
2020
Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases
A Steindl, S Yadavalli, KA Gruber, M Seiwald, B Gatterbauer, ...Cancer 126 (19), 4341-4352, 2020202
27
2020
Cancer rehabilitation: current trends and practices within an Austrian University Hospital Center
R Crevenna, F Kainberger, C Wiltschke, C Marosi, M Wolzt, F Cenik, ...Disability and Rehabilitation 42 (1), 2-7, 2020202
25
2020
Prognostic impact of genetic alterations and methylation classes in meningioma
AS Berghoff, T Hielscher, G Ricken, J Furtner, D Schrimpf, G Widhalm, ...Brain Pathology 32 (2), e12970, 2022202
21
2022
Distributed changes of the functional connectome in patients with glioblastoma
KH Nenning, J Furtner, B Kiesel, E Schwartz, T Roetzer, N Fortelny, ...Scientific reports 10 (1), 18312,
20
2020
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
M Preusser, A Silvani, E Le Rhun, R Soffietti, G Lombardi, JM Sepulveda, ...Neuro-oncology 24 (5), 755-767, 2022202
18
2022
Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
F Erhart, M Hackl, H Hahne, J Buchroithner, C Meng, S Klingenbrunner, ...npj Vaccines 5 (1), 5, 2020202
16
2020
Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
MJ Mair, S Pajenda, A Ilhan-Mutlu, A Steindl, B Kiesel, G Widhalm, ...ESMO open 5 (6), e000863, 2020202
13
2020
Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebo …
M Frass, P Lechleitner, C Gründling, C Pirker, E Grasmuk-Siegl, ...The Oncologist 26 (3), e523-e523, 2021202
13
2021
GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
H Arfsten, A Cho, C Freitag, M Raderer, G Goliasch, PE Bartko, R Wurm, ...European journal of clinical investigation 49 (11), e13168, 2019201
12
2019
Low systemic levels of chemokine CC motif ligand 3 (CCL3) are associated with a high risk of venous thromboembolism in patients with glioma
P Mir Seyed Nazari, C Marosi, F Moik, J Riedl, Ö Özer, AS Berghoff, ...Cancers 11 (), 2020, 2019201
12
2019
Analysis of the inflammatory tumor microenvironment in meningeal neoplasms
AS Berghoff, P Kresl, O Rajky, G Widhalm, G Ricken, JA Hainfellner, ...Clinical neuropathology 39 (6), 256, 2020202
11
2020
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer
AS Berghoff, C Wippel, AM Starzer, N Ballarini, F Wolpert, E Bergen, ...European Journal of Cancer 135, 150-158, 2020202
10
2020
Applied precision cancer medicine in neuro-oncology
H Taghizadeh, L Müllauer, J Furtner, JA Hainfellner, C Marosi, ...Scientific Reports 9 (1), 20139, 2019201
10
2019
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
MJ Mair, A Ilhan-Mutlu, S Pajenda, B Kiesel, A Wöhrer, G Widhalm, ...Cancer Immunology, Immunotherapy 0 (12), 3643-3650, 2021202
7
2021
Guiding treatment choices for elderly patients with glioblastoma by a comprehensive geriatric assessment
C Lütgendorf-Caucig, C Freyschlag, EK Masel, C MarosiCurrent Oncology Reports 22, 1-8, 2020202
7
2020
Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death
F Posch, S Hofer, J Thaler, L Hell, O Königsbrügge, E Grilz, ...Translational Research 215, 41-5, 2020202
6
2020

Referred From: https://scholar.google.com/citations?user=TqO1CO8AAAAJ&hl=de

Cited by
Citations 48514
h-index 69
i10-index 216
Recommended Journals
Open Access Journals